Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026)
Design Therapeutics (DSGN) posted quarterly EPS (Basic) of -$0.37 for Q2 2026, up 2.52% year-over-year from -$0.36 in Q2 2025, and down 9.49% on a QoQ basis from -$0.34 in Q1 2026.
Powered by 
Analysis
Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026) Analysis & Trends
Design Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.37 in Q2 2026.
- EPS (Basic) for Q2 2026 came in at -$0.37, up 2.52% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.31 (down 1.03% YoY), and the FY2025 annual result was -$938.29, down 169.54% from the prior year.
- EPS (Basic) slipped to -$0.37 in Q2 2026, from -$0.34 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.24 in Q1 2024 and troughed at -$189.42 in Q4 2022.
- A 5-year average of -$10.88 and a median of -$0.37 in 2026 frame the typical range for EPS (Basic).
- The widest annual swing landed in 2022, when EPS (Basic) tumbled 76449.86%; it then soared 99.54% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$189.42 in 2022, then soared by 99.54% to -$0.86 in 2023, then surged by 66.64% to -$0.29 in 2024, then dropped by 10.19% to -$0.32 in 2025, then decreased by 17.96% to -$0.37 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.37 in Q2 2026, -$0.34 in Q1 2026, and -$0.32 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Design Therapeutics | 945.71 Mn | 738.31 Mn | - | -0.37 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.37 |
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.32 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.29 |
| Sep 30, 2024 | -0.27 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.30 |
| Mar 31, 2022 | -0.26 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | -0.21 |